Shoichi Hishinuma

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi et al. · The Lancet · 2016 · 1.1K citations

Surgical Oncology, Oncology, Pancreatic Cancer +6

Patterns of Recurrence After Curative Resection of Pancreatic Cancer, Based on Autopsy Findings

Shoichi Hishinuma, Moriaki Tomikawa, Iwao Ozawa et al. · Journal of Gastrointestinal Surgery · 2006 · 331 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +11

Carbon Ion Radiation Therapy With Concurrent Gemcitabine for Patients With Locally Advanced Pancreatic Cancer

Makoto Shinoto, Shigeru Yamada, Kotaro Terashima et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 147 citations

Surgical Oncology, Radiation Medicine, Concurrent Gemcitabine +5

A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer

Masayuki Imamura, Ryuichiro Doi, Toshihide Imaizumi et al. · Surgery · 2004 · 124 citations

Surgical Oncology, Pancreatic Cancer, Gastrointestinal Oncology +7

Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: Final results of a randomized multi-institutional trial

Ryuichiro Doi, Masayuki Imamura, Ryo Hosotani et al. · Surgery Today · 2008 · 118 citations

Surgical Oncology, Surgery Versus Radiochemotherapy, Pancreatic Cancer +7